+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030- Product Image
Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030- Product Image
New

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application, By End Use, By Region, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 4661562
Description Jump to:

Women's Health Diagnostics Market Growth & Trends

The global women’s health diagnostics market size is expected to reach USD 31.46 billion by 2030. The market is expected to expand at a CAGR of 7.29% from 2025 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women’s health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2024. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 46.21% in 2024. It is anticipated to maintain its dominance through 2030, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End Use
1.2.3. Regional Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Women’s Health Diagnostics Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of various health conditions in women
3.2.1.2. Growing women health awareness,
3.2.1.3. Technological advancements in diagnostics equipment
3.2.1.4. Aging women population
3.2.1.5. Developing global healthcare infrastructure
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of access of diagnostic solutions
3.2.2.2. High cost of diagnostic solutions
3.3. Women’s Health Diagnostics Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Women’s Health Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Application Market Share Analysis, 2024 & 2030
4.3. Women’s Health Diagnostics Market, by Application, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4.1. Cancer
4.4.1.1. Cancer market, 2018 - 2030 (USD Million)
4.4.2. Infectious diseases
4.4.2.1. Infectious diseases market, 2018 - 2030 (USD Million)
4.4.3. Osteoporosis
4.4.3.1. Osteoporosis market, 2018 - 2030 (USD Million)
4.4.4. Pregnancy & fertility
4.4.4.1. Pregnancy & fertility market, 2018 - 2030 (USD Million)
4.4.5. Prenatal
4.4.5.1. Prenatal market, 2018 - 2030 (USD Million)
Chapter 5. Women’s Health Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2030
5.3. Global Women’s Health Diagnostics Market, by End Use, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1. Hospitals
5.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
5.4.2. Laboratory
5.4.2.1. Laboratory market, 2018 - 2030 (USD Million)
5.4.3. Home care
5.4.3.1. Home care market, 2018 - 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market, 2018 - 2030 (USD Million)
Chapter 6. Women’s Health Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Asia Pacific
6.5.1. China
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. UAE
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Kuwait
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Recent Developments & Impact Analysis by Key Market Participants
7.3. Company Market Share Analysis, 2024
7.4. Key Company Profiles
7.4.1. F. Hoffmann-La Roche Ltd.
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Hologic, Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Quest Diagnostics Incorporated
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Abbott
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. BD
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. GE Healthcare
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Koninklijke Philips N.V.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Aspira Women's Health
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Thermo Fisher Scientific Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Cardinal Health, Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America women’s health diagnostics market, by country, 2018 - 2030 (USD Million)
Table 4. North America women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5. North America women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6. U.S. women’s health diagnostics, by application, 2018 - 2030 (USD Million)
Table 7. U.S. women’s health diagnostics, by end use, 2018 - 2030 (USD Million)
Table 8. Canada women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 9. Canada women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 10. Mexico women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 11. Mexico women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12. Europe women’s health diagnostics market, by country, 2018 - 2030 (USD Million)
Table 13. Europe women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14. Europe women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15. UK women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 16. UK women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 17. Germany women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 18. Germany women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 19. France women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 20. France women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 21. Italy women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 22. Italy women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 23. Spain women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 24. Spain women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 25. Norway women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 26. Norway women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 27. Sweden women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 28. Sweden women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 29. Denmark women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 30. Denmark women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 31. Asia Pacific women’s health diagnostics market, by country, 2018 - 2030 (USD Million)
Table 32. Asia Pacific women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 33. Asia Pacific women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 34. China women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 35. China women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 36. Japan women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 37. Japan women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 38. India women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 39. India women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 40. Australia women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 41. Australia women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 42. South Korea women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 43. South Korea women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 44. Thailand women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 45. Thailand women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 46. Latin America women’s health diagnostics market, by country, 2018 - 2030 (USD Million)
Table 47. Latin America women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 48. Latin America women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49. Brazil women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 50. Brazil women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 51. Argentina women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 52. Argentina women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 53. Colombia women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 54. Colombia women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 55. Middle East & Africa women’s health diagnostics market, by country, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa women’s health diagnostics, by bag usage, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 58. South Africa women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 59. South Africa women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 60. Saudi Arabia women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 62. UAE women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 63. UAE women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 64. Kuwait women’s health diagnostics market, by application, 2018 - 2030 (USD Million)
Table 65. Kuwait women’s health diagnostics market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Women's health diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2024)
Fig. 10 Segment Outlook
Fig. 11 Strategy framework
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Women's health diagnostics market: Application movement analysis
Fig. 18 Women's health diagnostics market application outlook: Key takeaways
Fig. 19 Cancer market, 2018 - 2030 (USD Million)
Fig. 20 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 21 Osteoporosis market, 2018 - 2030 (USD Million)
Fig. 22 Pregnancy & fertility market, 2018 - 2030 (USD Million)
Fig. 23 Prenatal market, 2018 - 2030 (USD Million)
Fig. 24 Women's health diagnostics market: End Use movement analysis
Fig. 25 Women's health diagnostics market end use outlook: Key takeaways
Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
Fig. 27 Laboratory market, 2018 - 2030 (USD Million)
Fig. 28 Home care market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Regional outlook, 2019 & 2027
Fig. 31 Regional market place: Key takeaways
Fig. 32 North America, SWOT, by PEST
Fig. 33 Europe, SWOT, by PEST
Fig. 34 Asia Pacific, SWOT, by PEST
Fig. 35 Latin America, SWOT, by PEST
Fig. 36 Middle East and Africa,, SWOT, by PEST
Fig. 37 North America women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 38 US women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 39 Canada women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 40 Mexico women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 41 Europe women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 42 UK women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 43 Germany women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 44 France women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 45 Italy women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 46 Spain women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 47 Norway women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 48 Denmark women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 49 Sweden women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 51 Japan women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 52 China women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 53 India women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 54 Australia women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 55 South Korea women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 Thailand women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 57 Latin America women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 58 Brazil women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 59 Argentina women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 60 MEA women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 61 South Africa women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 62 Saudi Arabia women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 63 UAE women’s health diagnostics market, 2018 - 2030 (USD Million)
Fig. 64 Kuwait women’s health diagnostics market, 2018 - 2030 (USD Million)

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Quest Diagnostics Incorporated
  • Abbott
  • BD
  • Ge Healthcare
  • Koninklijke Philips N.V.
  • Aspira Women's Health
  • Thermo Fisher Scientific Inc.
  • Cardinal Health, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 20.6 billion
Forecasted Market Value ( USD ) by 2030 $ 31.46 billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Women's Health Diagnostics Market by Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Women's Health Diagnostics Market by Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Women's Health Diagnostics - Global Strategic Business Report - Product Image

Women's Health Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Women Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Women Health Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032 - Product Image

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Womens Health Diagnostics Market 2024-2028 - Product Image

Womens Health Diagnostics Market 2024-2028

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.